Prof Research published a new market report on coronary artery bypass graft devices. It presents the largest 6 manufacturers in coronary artery bypass graft devices Market. The report is a professional and in-depth study on the current state of the global coronary artery bypass graft devices market. The report provides key statistics on the market of coronary artery bypass graft devices. This report covers 1 product: coronary artery bypass graft devices. It is a valuable source of guidance and direction for companies and individuals interested in the industry of coronary artery bypass graft devices.

The global coronary artery bypass graft devices market was valued at 739.9 million USD in 2021. The coronary artery bypass graft devices production value is anticipated to have grown with a CAGR of 4.42% in the coming years to reach 959.3 million USD in 2027.

Medtronic, is the largest manufacturer of coronary artery bypass graft devices in the world, and it has a market share of 31.1% in value. Medtronic plc is a global healthcare technology company. It develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes.

Terumo is the second largest manufacturer of coronary artery bypass graft devices in the world, and it has a market share of 23.8% in value. TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments:the Cardiac and Vascular Company segment, the Hospital Company segment, and the Blood System Company segment.

B. Braun is the third largest manufacturer of coronary artery bypass graft devices in the world, and it has a market share of 18.7% in value. B. Braun is a German medical and pharmaceutical device company. The company’s operations are organized into three divisions – Hospital Care, Aesculap, and Avitum.

Getinge is the fourth largest manufacturer of coronary artery bypass graft devices in the world, and it has a market share of 12.4% in value. Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies, Life Science, and Surgical Workflows.